2. Anti-infection Cell Cycle/DNA Damage
  3. HIV Reverse Transcriptase DNA/RNA Synthesis
  4. Soulattrolide

Soulattrolide is a non-nucleoside HIV-1 reverse transcriptase (RT) inhibitor with IC50 values of 0.34 µM for HIV-1 RT, 69.5 µM for E. coli RNase H, and >495 µM for human DNA polymerase β, and can be found in Calophyllum teysmannii latex. Soulattrolide can be used for the research of HIV-1 infection, pain, inflammation, and Mycobacterium tuberculosis infection.

For research use only. We do not sell to patients.

Soulattrolide

Soulattrolide Chemical Structure

CAS No. : 65025-62-9

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Soulattrolide Related Antibodies

Top Publications Citing Use of Products

View All HIV Isoform Specific Products:

View All Isoforms
HIV HIV-1 HIV-2

View All DNA/RNA Synthesis Isoform Specific Products:

View All Isoforms
RNASE L DNA Polymerases RNA Polymerases Helicases DNA Ligase

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Soulattrolide is a non-nucleoside HIV-1 reverse transcriptase (RT) inhibitor with IC50 values of 0.34 µM for HIV-1 RT, 69.5 µM for E. coli RNase H, and >495 µM for human DNA polymerase β, and can be found in Calophyllum teysmannii latex. Soulattrolide can be used for the research of HIV-1 infection, pain, inflammation, and Mycobacterium tuberculosis infection[1][2].

IC50 & Target[1]

HIV-1

0.34 μM (IC50)

DNA Polymerase

>495 μM (IC50)

Cellular Effect
Cell Line Type Value Description References
Vero LD50
10 μg/mL
Compound: 13
Cytotoxicity against African green monkey Vero cells by CellTiter 96 non-radioactive cell proliferation assay
Cytotoxicity against African green monkey Vero cells by CellTiter 96 non-radioactive cell proliferation assay
[PMID: 28494250]
In Vitro

Soulattrolide (Compound 1) (1.0×10-9-5.0×10-4 M; 1 h) potently inhibits the RNA-dependent DNA polymerase activity of purified dimeric HIV-1 (p66/p51) reverse transcriptase with an IC50 of 0.34 µM[1].
Soulattrolide (1.0×10-9-5.0×10-4 M; 1 h) inhibits the DNA-dependent DNA polymerase activity of purified dimeric HIV-1 (p66/p51) reverse transcriptase with an IC50 of 0.73 µM[1].
Soulattrolide (1.0×10-9-5.0×10-4 M; 30 min) inhibits purified Escherichia coli ribonuclease H activity with an IC50 of 69.5 µM[1].
Soulattrolide (495 µM; 1 h) shows no significant inhibitory activity against HIV-2 RT, TIBO-resistant (Tyr181) HIV-1 RT, avian myeloblastosis virus RT, human DNA polymerase α, human DNA polymerase β, or Escherichia coli RNA polymerase at concentrations up to 495 µM[1].
Soulattrolide (0.34 μM) potently inhibits HIV-1 reverse transcriptase with an IC50 of 0.34 μM in a cell-free biochemical assay[2].
Soulattrolide (3.13 μg/mL) inhibits Mycobacterium tuberculosis growth with an MIC of 3.13 μg/mL in a cell-free/biochemical assay[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Soulattrolide Related Antibodies
In Vivo

Soulattrolide (Compound 1) (0.1-50 mg/kg; p.o.; single dose) exerts dose-dependent antinociceptive activity in the acetic acid (10mL/kg)-induced mice writhing model with an ED50 of 33 mg/kg (p.o.)[2].
Soulattrolide (0.1-50 mg/kg; p.o.; single dose) exhibits antinociceptive activity in both neurogenic (ED50 = 7 mg/kg p.o.) and inflammatory (ED50 = 22 mg/kg p.o.) phases of the formalin (30 μL)-induced mice paw licking model[2].
Soulattrolide (0.1-50 mg/kg; p.o.; single dose) induces 40% antinociception in the mice hot plate thermal nociception model when evaluated 120 minutes post-treatment[2].
Soulattrolide (0.1-10 μmol/ear; topical; single dose) exerts dose-dependent anti-inflammatory activity in the TPA (0.25 μg/μL)-induced mice ear edema model with an IC50 of 1.81 μmol/ear, and inhibits MPO activity by 87% at 1 μmol/ear[2].
Soulattrolide (1-50 mg/kg; p.o.; single dose) exerts sedative effects in the pentobarbital-induced mice sleeping time model, decreasing sleep onset by up to 39% and increasing sleep duration by up to 49%[2].
Soulattrolide (1-50 mg/kg; p.o.; single dose) impairs motor coordination in the mice rotarod model at 10 and 50 mg/kg with a transient effect that resolves by 60 minutes post-treatment initiation[2].
Soulattrolide (1-50 mg/kg; p.o.; single dose) lacks antidepressant activity in the mice tail suspension test[2].
Soulattrolide (1-50 mg/kg; p.o.; single dose) exhibits anxiolytic-like effects in the mice light-dark test significantly increasing time spent in the light compartment[2].
Soulattrolide (1-50 mg/kg; p.o.; single dose) exhibits anxiolytic-like effects in the open field test, increasing the distance of mice crossed in central squares in a dose-dependent manner[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Balb/c, CD-1 (male, 25-30 g)[2]
Dosage: 0.1 mg/kg; 1 mg/kg; 10 mg/kg; 50 mg/kg
Administration: p.o.; single dose
Result: Showed dose-dependent antinociceptive effects with an ED50 = 33 mg/kg.\nShowed antinociceptive activity in both phases of the formalin test, with an ED50 = 7 mg/kg for Phase 1 and an ED50 = 22 mg/kg for Phase 2.\nInduced 40% antinociception compared to the vehicle group 120 minutes post-treatment at the highest dose of 50 mg/kg.
Animal Model: Balb/c, CD-1 (male, 25-30 g)[2]
Dosage: 0.1 μmol/ear; 1 μmol/ear; 10 μmol/ear
Administration: topical; single dose
Result: Showed dose-dependent anti-inflammatory activity with an IC50 = 1.81 μmol/ear in the TPA edema test.
Inhibited MPO activity by 87% at 1 μmol/ear.
Animal Model: Balb/c, CD-1 (male, 25-30 g)[2]
Dosage: 1 mg/kg; 10 mg/kg; 50 mg/kg
Administration: p.o.; single dose
Result: Significantly decreased sleep onset by 21% (1 mg/kg), 19% (10 mg/kg), and 39% (50 mg/kg) compared to the vehicle group.
Significantly increased sleep duration by 42% (1 mg/kg), 46% (10 mg/kg), and 49% (50 mg/kg) compared to the vehicle group.\nSignificantly decreased time spent on the rotarod by 12% (10 mg/kg) and 22% (50 mg/kg) at 30 minutes post-treatment initiation.
Allowed mice to recover motor coordination by 60 minutes post-treatment initiation.\nDid not affect immobility time compared to the vehicle group.\nSignificantly increased time spent in the light compartment compared to the vehicle group, with effects similar to clonazepam (1.5 mg/kg), though not dose-dependent.\nSignificantly increased distance crossed in central squares in a dose-dependent manner, with effects similar to clonazepam (1.5 mg/kg).
Molecular Weight

404.46

Formula

C25H24O5
CAS No.
SMILES

O[C@@H]1C2=C(O[C@H]([C@@H]1C)C)C(C=CC(C)(O3)C)=C3C(C(C4=CC=CC=C4)=C5)=C2OC5=O
Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Soulattrolide Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Soulattrolide65025-62-9HIVReverse TranscriptaseDNA/RNA SynthesisHuman immunodeficiency virusCalophyllum teysmanniiHIV-2 RTE. coli RNase HAMV RTMycobacterium tuberculosisTyr181 mutant HIV-1 RTHIV-1 reverse transcriptasehuman DNA polymerase βRNA polymeraseavian myeloblastosis virus RTInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Soulattrolide
Cat. No.:
HY-182552
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.